TF002

· JADO Technologies GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TF002, covering 2007-11-12 to 2007-11-12. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of TF002 in Cutaneous Mastocytosis [Phase 2]